|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-12-19
|
|
pubmed:abstractText |
In a prospective randomized study, the impact of plasma protease inhibitor (PI) trough levels on changes in HIV RNA were assessed in patients treated with genotypic-guided therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1333-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10930147-Adult,
pubmed-meshheading:10930147-Drug Resistance, Microbial,
pubmed-meshheading:10930147-Female,
pubmed-meshheading:10930147-Genotype,
pubmed-meshheading:10930147-HIV Infections,
pubmed-meshheading:10930147-HIV Protease Inhibitors,
pubmed-meshheading:10930147-HIV-1,
pubmed-meshheading:10930147-Humans,
pubmed-meshheading:10930147-Male,
pubmed-meshheading:10930147-Middle Aged,
pubmed-meshheading:10930147-RNA, Viral,
pubmed-meshheading:10930147-Treatment Failure
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.
|
|
pubmed:affiliation |
Archet Hospital, Infectious Diseases Department, Nice, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
